RESUMEN
Tough issues like sodium (Na) dendrite growth and poor anode reversibility hinder the practical application of sodium metal batteries (SMBs) with moderate liquid electrolytes. To settle these problems, using a smart self-adapting Al2SiO5 ceramic fiber (CF) membrane is demonstrated to enable homogeneous Na depositions and inhibit the dendritic growth. This inorganic membrane itself has superb thermal stability, high ionic mobility (Na+ transference number: 0.65) and electrolyte wettability over traditional glass fiber (GF) or polymeric ones, guaranteeing the low voltage polarization (14 mV) and long-cyclic lifetime (over 600 h) in symmetric cells testing. Notably, aluminous components in CF membranes would interact with F-based molecules in the electrolyte phase, thereby releasing some Al3+ species that can be electrochemically deposited onto the anodic interface. The packed (+)Na3V2(PO4)3|CF|Na(-) full SMBs exhibit far superior cyclic stability (capacity retention over 78.7 % after 600 cycles at 1C) than other counterparts. The in-situ detection/postmortem analysis reveal that Al/F-based inorganics formed in as-built SEI layers play a vital role in Na metal anode protection. This work may provide a viable strategy to overcome the constraints of high-energy SMBs in practical applications.
RESUMEN
INTRODUCTION: Poststroke depression is a serious and common complication of stroke, especially the ischemic poststroke depression. Antidepressants are used in poststroke depression, and acupuncture may be an alternative approach. However, the efficacy and mechanism of acupuncture for poststroke depression has not been confirmed. METHODS/DESIGN: This is a multicenter, central-randomized, single-blind, sham-controlled clinical trial. We will allocate 208 subjects aged between 40 and 80 years old, diagnosed with initial poststroke depression (PSD) within 6 months to 2 groups randomly in a ratio of 1:1. Patients in the experimental group will be treated with traditional acupuncture and placebo pills, whereas the others in the control group will be treated with sham-acupoints acupuncture and antidepressant (fluoxetine hydrochloride tablets). All will be given acupuncture and/or medication treatment for 12 weeks, and then received 12-week follow-up. Patients will be evaluated with the 17-item Hamilton Depression Scale and Se1f-rating Depression Scale for depression state, National Institute of Health Stroke Scale for neurological deficit, Modified Barthel Index for activities of daily living, Treatment Emergent Symptom Scale for side effects of treatments, diagnosis and evaluation criteria of traditional Chinese medicine for stroke (try out) for curative effects of stroke, and clinical global impression for synthesize effect before and the 2nd, 4th, 8th, and 12th week of treatment, 24th week of follow-up. Study on mechanisms of acupuncture will be revealed through the diversity of brain metabolites (choline-containing compounds [Cho], N-acetylaspartate [NAA], myoinositol, glutamine and glutamate complex, creatine [Cr], Cho/Cr, Cho/NAA, Cr/NAA) in bilateral dorsolateral prefrontal cortex and anterior cingulate cortex monitored by proton magnetic resonance spectroscopy, and serum monoamine neurotransmitters (5-hydroxytryptamine, norepinephrine, dopamine) and cytokines (brain-derived neurotrophic factor [BDNF], interleukin [IL]-4, IL-6, IL-10, IL-18, IL-1ß, tumor necrosis factor alpha) before and the 12th week of treatment. Baseline characteristics of patients will be summarized by groups and compared with chi-square for categorical variables, and 2-sample t tests or Wilcoxon rank-sum test for the continuous variables. Primary and secondary outcomes according to the measurement times are applicable to univariate repetitive measurement deviation analysis or 2-sample t tests, or Wilcoxon rank-sum test. CONCLUSION: The present research is designed to investigate efficacy and mechanism of traditional acupuncture therapy on ischemic PSD, also to explore the correlation between cerebra metabolic and serologic factors, and ischemic PSD. With this research, we are looking forward to find out an appropriate alternative nondrug therapy for PSD people to alleviate the adverse effects and drug dependence caused by antidepressants.
